Center for Scientific Review; Notice of Closed Meetings, 3807-3809 [2016-01196]

Download as PDF 3807 Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices information collection requirements contained in the Rule. 45 CFR 164.508: This provision requires covered entities to obtain or receive a valid authorization for its use or disclosure of protected health information for other than for treatment, payment and healthcare operations. Under the provision individuals may initiate a written authorization permitting covered entities to release their protected health information to entities of their choosing. The form IHS–810 ‘‘Authorization for Use or Disclosure of Protected Health Information’’ is used to document an individual’s authorization to use or disclose their protected health information. 45 CFR 164.522: Section 164.522(a)(1) requires a covered entity to permit individuals to request that the covered entity restrict the use and disclosure of their protected health information. The covered entity may or may not agree to the restriction. The form IHS–912–1 ‘‘Request for Restrictions(s)’’ is used to document an individual’s request for restriction of their protected health information, and whether IHS agreed or disagreed with the restriction. Section 164.522(a)(2) permits a covered entity to terminate its agreement to a restriction if the individual agrees to or requests the termination in writing. The form IHS–912–2 ‘‘Request for Revocation of Restriction(s)’’ is used to document the agency or individual request to terminate a formerly agreed to restriction regarding the use and disclosure of protected health information. 45 CFR 164.528 and 45 CFR 5b.9(c): This provision requires covered entities to permit individuals to request that the covered entity provide an accounting of disclosures of protected health information made by the covered entity. The form IHS–913 ‘‘Request for an Accounting of Disclosures’’ is used to document an individual’s request for an accounting of disclosures of their protected health information and the agency’s handling of the request. 45 CFR 164.526: This provision requires covered entities to permit an individual to request that the covered entity amend protected health Number of responses per respondent Average burden hour per response * 210,954 214 1 1 10/60 10/60 35,159 36 3 1 10/60 .5 39 1 10/60 6.5 54 1 10/60 9 211,264 ........................ ........................ 35,211 Number of respondents Data collection instrument Authorization for Use or Disclosure of Protected Health Information (OMB Form No. 0917–0030, IHS–810) .................................................................. Request for Restriction(s) (OMB Form No. 0917–0030, IHS–912–1) ............ Request for Revocation of Restriction(s) (OMB Form No. 0917–0030, IHS– 912–2) .......................................................................................................... Request for Accounting of Disclosures (OMB Form No. 0917–0030, IHS– 913) .............................................................................................................. Request for Correction/Amendment of Protected Health Information (OMB Form No. 0917–0030, IHS–917) .................................................................. Total Annual Burden ................................................................................. information. If the covered entity accepts the requested amendment, in whole or in part, the covered entity must inform the individual that the amendment is accepted. If the covered entity denies the requested amendment, in whole or in part, the covered entity must provide the individual with a written denial. The form IHS–917 ‘‘Request for Correction/Amendment of Protected Health Information’’ will be used to document an individual’s request to amend their protected health information and the agency’s decision to accept or deny the request. Completed forms used in this collection of information are filed in the IHS medical, health and billing record, a Privacy Act System of Records Notice. Affected Public: Individuals and households. Type of Respondents: Individuals. Burden Hours: The table below provides for this information collection: Types of data collection instruments, estimated number of respondents, number of responses per respondent, average burden hour per response, and total annual burden hour(s). Total annual burden hours mstockstill on DSK4VPTVN1PROD with NOTICES * For ease of understanding, burden hours are provided in actual minutes. The total estimated burden for this collection of information is 35,211 hours. There are no capital costs, operating costs and/or maintenance costs to respondents. Requests for Comments: Your written comments and/or suggestions are invited on one or more of the following points: (a) Whether the information collection activity is necessary to carry out an agency function; (b) whether the agency processes the information collected in a useful and timely fashion; (c) the accuracy of the public burden estimate (the estimated amount of time needed for individual respondents to provide the requested information); (d) whether the methodology and assumptions used to determine the estimates are logical; VerDate Sep<11>2014 16:59 Jan 21, 2016 Jkt 238001 (e) ways to enhance the quality, utility, and clarity of the information being collected; and (f) ways to minimize the public burden through the use of automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Dated: January 13, 2016. Robert G. McSwain, Principal Deputy Director, Indian Health Service. [FR Doc. 2016–01208 Filed 1–21–16; 8:45 am] BILLING CODE 4165–16–P PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\22JAN1.SGM 22JAN1 3808 Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Developmental Brain Disorders Study Section. Date: February 4–5, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA 92101. Contact Person: Pat Manos, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–408– 9866, manospa@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section. Date: February 4–5, 2016. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton La Jolla Hotel, 3299 Holiday Court, La Jolla, CA 92037. Contact Person: Julius Cinque, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, cinquej@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cellular Aspects of Diabetes and Obesity. Date: February 9, 2016. Time: 8:00 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD 20892, 301 435– 2514, riverase@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Pathophysiological Basis of Mental Disorders and Addictions Study Section. Date: February 11–12, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: New Orleans Downtown Marriott at the Convention Center, 859 Convention Center Boulevard, New Orleans, LA 70130. Contact Person: Boris P. Sokolov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301–408– 9115, bsokolov@csr.nih.gov. Name of Committee: Oncology 1—Basic Translational Integrated Review Group; Cancer Etiology Study Section. Date: February 11, 2016. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott—Bethesda North, 5701 Marinelli Road, North Bethesda, MD 20852. VerDate Sep<11>2014 16:59 Jan 21, 2016 Jkt 238001 Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr. Room 4192, MSC 7806, Bethesda, MD 20892, 301–451–4467, howardz@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–15– 276: Turkey-US Collaborative Program for Affordable Medical Technologies (R01). Date: February 16, 2016. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, (301) 435– 3504, tothct@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Cellular, Molecular and Integrative Reproduction Study Section. Date: February 17–18, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gary Hunnicutt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6164, MSC 7892, Bethesda, MD 20892, 301–435– 0229, hunnicuttgr@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Molecular and Cellular Endocrinology Study Section. Date: February 17–18, 2016. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: John Bleasdale, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6170 MSC 7892, Bethesda, MD 20892, 301–435– 4514, bleasdaleje@csr.nih.gov. Name of Committee: Oncology 1—Basic Translational Integrated Review Group; Tumor Microenvironment Study Section. Date: February 17–18, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Angela Y. Ng, Ph.D., MBA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD 20892, 301–435– 1715, ngan@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Biophysical and Biomechanical Aspects of Embryonic Development. Date: February 17–18, 2016. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Charles Selden, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Room 5187 MSC 7840, Bethesda, MD 20892, 301–451–3388, seldens@mail.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Chronic Dysfunction and Integrative Neurodegeneration Study Section. Date: February 18–19, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott at the Convention Center, 859 Convention Center Boulevard, New Orleans, LA 70130. Contact Person: Alexei Kondratyev, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–435– 1785, kondratyevad@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Clinical Research and Field Studies of Infectious Diseases Study Section. Date: February 18, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301–435– 0903, saadisoh@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Synapses, Cytoskeleton and Trafficking Study Section. Date: February 18–19, 2016. Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Row Hotel, 2015 Massachusetts Avenue, Washington, DC 20036. Contact Person: Christine A. Piggee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4186, MSC 7850, Bethesda, MD 20892, 301–435– 0657, christine.piggee@nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Neurotransporters, Receptors, and Calcium Signaling Study Section. Date: February 18–19, 2016. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101. Contact Person: Peter B. Guthrie, Ph.D., Scientific Review Officer, Center for E:\FR\FM\22JAN1.SGM 22JAN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 14 / Friday, January 22, 2016 / Notices Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD 20892, (301) 435– 1239, guthriep@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Molecular and Integrative Signal Transduction Study Section. Date: February 18–19, 2016. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Raya Mandler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5134, MSC 7840, Bethesda, MD 20892, (301) 402– 8228, rayam@csr.nih.gov. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group; Myocardial Ischemia and Metabolism Study Section. Date: February 18–19, 2016. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Riverwalk Marriott, 207 N. St. Mary’s Street, San Antonio, TX 78205. Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301–435– 5575, hamannkj@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Pathogenic Eukaryotes Study Section. Date: February 18–19, 2016. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Best Western Tuscan Inn, 425 North Point Street, San Francisco, CA 94133. Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD 20892, (301) 435– 2306, boundst@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Molecular Genetics A Study Section. Date: February 18–19, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Michael M. Sveda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301–435– 3565, svedam@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) VerDate Sep<11>2014 16:59 Jan 21, 2016 Jkt 238001 Dated: January 15, 2016. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2016–01196 Filed 1–21–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH Pathway to Independence Awards (K99). Date: February 17, 2016. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: David W. Miller, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–9734, millerda@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Developmental/Early Phase Clinical Trials. Date: February 18, 2016. Time: 9:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: David I. Sommers, Ph.D., Scientific Review Officer Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9606, Bethesda, MD 20892–9606, 301–443–7861, dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Longitudinal Study—PTSD. PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 3809 Date: February 23, 2016. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: David I. Sommers, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Room 6154, MSC 9606, Bethesda, MD 20892–9606, 301–443–7861, dsommers@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34). Date: February 23, 2016. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Dupont Hotel, 1500 New Hampshire Avenue NW., Washington, DC 20036. Contact Person: Aileen Schulte, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–1225, aschulte@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: January 14, 2016. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–01197 Filed 1–21–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Initial Review Group; Mental Health Services Research Committee. E:\FR\FM\22JAN1.SGM 22JAN1

Agencies

[Federal Register Volume 81, Number 14 (Friday, January 22, 2016)]
[Notices]
[Pages 3807-3809]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01196]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 3808]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Developmental Brain Disorders Study 
Section.
    Date: February 4-5, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA 
92101.
    Contact Person: Pat Manos, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-408-
9866, manospa@csr.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Neural Basis of Psychopathology, Addictions 
and Sleep Disorders Study Section.
    Date: February 4-5, 2016.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton La Jolla Hotel, 3299 Holiday Court, La Jolla, CA 
92037.
    Contact Person: Julius Cinque, Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 5186, MSC 7846, Bethesda, MD 20892, cinquej@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Cellular Aspects of Diabetes and Obesity.
    Date: February 9, 2016.
    Time: 8:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review 
Officer, EMNR IRG, Center for Scientific Review, National Institutes 
of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD 
20892, 301 435-2514, riverase@csr.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Pathophysiological Basis of Mental 
Disorders and Addictions Study Section.
    Date: February 11-12, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: New Orleans Downtown Marriott at the Convention Center, 
859 Convention Center Boulevard, New Orleans, LA 70130.
    Contact Person: Boris P. Sokolov, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 
20892, 301-408-9115, bsokolov@csr.nih.gov.

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Cancer Etiology Study Section.
    Date: February 11, 2016.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott--Bethesda North, 5701 Marinelli Road, North 
Bethesda, MD 20852.
    Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Dr. Room 4192, MSC 7806, Bethesda, MD 20892, 
301-451-4467, howardz@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-15-276: Turkey-US Collaborative Program for Affordable 
Medical Technologies (R01).
    Date: February 16, 2016.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 
20892, (301) 435-3504, tothct@csr.nih.gov.

    Name of Committee: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences Integrated Review Group; Cellular, Molecular 
and Integrative Reproduction Study Section.
    Date: February 17-18, 2016.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Gary Hunnicutt, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6164, MSC 7892, Bethesda, MD 
20892, 301-435-0229, hunnicuttgr@csr.nih.gov.

    Name of Committee: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences Integrated Review Group; Molecular and 
Cellular Endocrinology Study Section.
    Date: February 17-18, 2016.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), 
8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: John Bleasdale, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6170 MSC 7892, Bethesda, MD 
20892, 301-435-4514, bleasdaleje@csr.nih.gov.

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Tumor Microenvironment Study Section.
    Date: February 17-18, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Angela Y. Ng, Ph.D., MBA, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD 
20892, 301-435-1715, ngan@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Biophysical and Biomechanical Aspects of Embryonic 
Development.
    Date: February 17-18, 2016.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Charles Selden, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive Room 5187 MSC 7840, Bethesda, MD 20892, 301-451-
3388, seldens@mail.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Chronic Dysfunction and Integrative 
Neurodegeneration Study Section.
    Date: February 18-19, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott at the Convention Center, 859 Convention Center 
Boulevard, New Orleans, LA 70130.
    Contact Person: Alexei Kondratyev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 
20892, 301-435-1785, kondratyevad@csr.nih.gov.

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Clinical Research and Field Studies of 
Infectious Diseases Study Section.
    Date: February 18, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Soheyla Saadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892, 301-435-
0903, saadisoh@csr.nih.gov.

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Synapses, Cytoskeleton and 
Trafficking Study Section.
    Date: February 18-19, 2016.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Row Hotel, 2015 Massachusetts Avenue, Washington, 
DC 20036.
    Contact Person: Christine A. Piggee, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4186, MSC 7850, Bethesda, MD 
20892, 301-435-0657, christine.piggee@nih.gov.

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Neurotransporters, Receptors, 
and Calcium Signaling Study Section.
    Date: February 18-19, 2016.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101.
    Contact Person: Peter B. Guthrie, Ph.D., Scientific Review 
Officer, Center for

[[Page 3809]]

Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4182, MSC 7850, Bethesda, MD 20892, (301) 435-1239, 
guthriep@csr.nih.gov.

    Name of Committee: Cell Biology Integrated Review Group; 
Molecular and Integrative Signal Transduction Study Section.
    Date: February 18-19, 2016.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Raya Mandler, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5134, MSC 7840, Bethesda, MD 20892, (301) 402-
8228, rayam@csr.nih.gov.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group; Myocardial Ischemia and Metabolism Study 
Section.
    Date: February 18-19, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Riverwalk Marriott, 207 N. St. Mary's Street, 
San Antonio, TX 78205.
    Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301-435-
5575, hamannkj@csr.nih.gov.

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Pathogenic Eukaryotes Study Section.
    Date: February 18-19, 2016.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Best Western Tuscan Inn, 425 North Point Street, San 
Francisco, CA 94133.
    Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD 
20892, (301) 435-2306, boundst@csr.nih.gov.

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Molecular Genetics A Study Section.
    Date: February 18-19, 2016.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue 
NW., Washington, DC 20037.
    Contact Person: Michael M. Sveda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 
20892, 301-435-3565, svedam@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 15, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-01196 Filed 1-21-16; 8:45 am]
 BILLING CODE 4140-01-P